Research / APYX / Fundamental state Inspectable configuration
State dimensions Filing 0001437749-25-007521 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
77.96% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity 67th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.50% · OPTIONAL · VALID
Operating cash generation 44th Own-history percentile · N=9
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-37.52% · OPTIONAL · VALID
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
-8.11% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure 0th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
15.72% · OPTIONAL · VALID
Gross margin 22th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.gross_margin
61.04% · CORE · VALID
Operating margin 56th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.operating_margin
-39.18% · CORE · VALID
R&D intensity 56th Own-history percentile · N=9
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
10.56% · OPTIONAL · VALID
SBC intensity 0th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
8.34% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 16 states History building
Sep 30, 2022 0/7 normalized Level 3 Dec 31, 2022 0/7 normalized Level 3 Mar 31, 2023 0/8 normalized Level 3 Jun 30, 2023 0/8 normalized Level 3 Sep 30, 2023 0/8 normalized Level 3 Dec 31, 2023 0/8 normalized Level 3 Mar 31, 2024 0/8 normalized Level 3 Jun 30, 2024 0/8 normalized Level 3 Sep 30, 2024 7/9 normalized Level 3 Dec 31, 2024 7/9 normalized Level 3 Mar 31, 2025 7/9 normalized Level 3 Jun 30, 2025 7/9 normalized Level 3 Sep 30, 2025 8/9 normalized Level 3 Dec 31, 2025 8/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 3 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 326.46%
Current 77.96%
Delta -248.50% Capex Intensity Increased
Previous 1.33%
Current 1.50%
Delta 0.17% Cash Generation Increased
Previous -38.65%
Current -37.52%
Delta 1.13% Growth Decreased
Previous -4.08%
Current -8.11%
Delta -4.03% Inventory Pressure Decreased
Previous 78.35%
Current 15.72%
Delta -62.62% Margin Increased
Previous 60.54%
Current 61.04%
Delta 0.50% Profitability Decreased
Previous -31.64%
Current -39.18%
Delta -7.53% R And D Intensity Increased
Previous 9.94%
Current 10.56%
Delta 0.62% Sbc Intensity Decreased
Previous 8.68%
Current 8.34%
Delta -0.34% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.